Clinical trial
Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness
NCT05367245 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 15, 2024
- Completion date
- March 31, 2027
- Enrollment
- 120 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic fatigue, gulf war illness, neurocognitive dysfunction